November 25, 2020
Rapid Dose Therapeutics Signs Definitive Agreement to Enable Commercial Production of Ultrapure THC™ Distillate Using RDT’s Novel CBD to THC Conversion Technology
Rapid Dose Therapeutics Signs Definitive Agreement to Enable Commercial Production of Ultrapure THC™ Distillate Using RDT’s Novel CBD to THC Conversion Technology
September 29, 2020
Rapid Dose Therapeutics Amends Agreement With Aphria to Produce in Burlington, Ontario Facility
Rapid Dose Therapeutics Amends Agreement With Aphria to Produce in Burlington, Ontario Facility
June 19, 2020
Rapid Dose Therapeutics Files a Patent to Synthesize THC From CBD Using a Selective Delta 8 or Delta 9 Conversion Process
Rapid Dose Therapeutics Files a Patent to Synthesize THC From CBD Using a Selective Delta 8 or Delta 9 Conversion Process